^
CANCER:

Peritoneal Cancer

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
No biomarker
Peritoneal Cancer
niraparib
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
bevacizumab + olaparib
Sensitive
:
A1
No biomarker
Peritoneal Cancer
bevacizumab
Sensitive
:
A1
No biomarker
Peritoneal Cancer
rucaparib
Sensitive
:
A1
No biomarker
Peritoneal Cancer
olaparib
Sensitive
:
A1
No biomarker
Peritoneal Cancer
bevacizumab-awwb
Sensitive
:
A1
No biomarker
Peritoneal Cancer
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Peritoneal Cancer
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
bevacizumab + olaparib
Sensitive
:
A1
HRD
Peritoneal Cancer
bevacizumab + olaparib
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
niraparib
Sensitive
:
A1
HRD
Peritoneal Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
olaparib
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
olaparib
Sensitive
:
A1
No biomarker
Peritoneal Cancer
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Peritoneal Cancer
bevacizumab-maly
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
pamiparib
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
pamiparib
Sensitive
:
A1
MSI-H/dMMR
Peritoneal Cancer
pembrolizumab
Sensitive
:
A2
No biomarker
Peritoneal Cancer
BEP
Sensitive
:
A2
TMB-H
Peritoneal Cancer
pembrolizumab
Sensitive
:
A2
No biomarker
Peritoneal Cancer
EP
Sensitive
:
A2
No biomarker
Peritoneal Cancer
VAC
Sensitive
:
A2
No biomarker
Peritoneal Cancer
IP
Sensitive
:
A2
No biomarker
Peritoneal Cancer
FOLFOX
Sensitive
:
A2
No biomarker
Peritoneal Cancer
CAPOX
Sensitive
:
A2
No biomarker
Peritoneal Cancer
sorafenib
Sensitive
:
A2
No biomarker
Peritoneal Cancer
topotecan
Sensitive
:
A2
No biomarker
Peritoneal Cancer
pegylated liposomal doxorubicin
Sensitive
:
A2